Association between incretin-related drugs and fractures in patients treated with pioglitazone: A pharmacovigilance study using the FDA Adverse Event Reporting System

Our results suggest that incretin-related drugs, especially GLP-1RAs, reduce the risk of fractures in patients treated with diabetes medications such as pioglitazone.

Authors

Publication Details

Journal
International Journal of Clinical Pharmacology and Therapeutics
Published
2025-10-22
DOI
https://doi.org/10.5414/cp204789
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association between incretin-related drugs and fractures in patients treated with pioglitazone: A pharmacovigilance study using the FDA Adverse Event Reporting System

Katsuhiro Ohyama, Noriko Abe, Yusuke Hori, Takumi Okamoto
International Journal of Clinical Pharmacology and Therapeutics
Pharmacovigilance and Adverse Drug Reactions
article

Association between incretin-related drugs and fractures in patients treated with pioglitazone: A pharmacovigilance study using the FDA Adverse Event Reporting System

Katsuhiro Ohyama, Noriko Abe, Yusuke Hori, Takumi Okamoto
article en

Abstract

Our results suggest that incretin-related drugs, especially GLP-1RAs, reduce the risk of fractures in patients treated with diabetes medications such as pioglitazone.

International Journal of Clinical Pharmacology and TherapeuticsVol. 64(01)
Openalex Percentile: Top 72%
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Association between incretin-related drugs and fractures in patients treated with pioglitazone: A pharmacovigilance study using the FDA Adverse Event Reporting System — Katsuhiro Ohyama, Noriko Abe, et al. · International Journal of Clinical Pharmacology and Therapeutics (2025) | TGRS Research Map | TGRS